SkinHealth Systems Inc. Income Tax Expense
SkinHealth Systems Inc. (SKIN) reported Income Tax Expense of $1.21 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-06
- SkinHealth Systems Inc. income tax expense (benefit) for the quarter ending 2026-06-30 was $1.21M.
- SkinHealth Systems Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was -$184.00K, a 120.63% decline year-over-year.
- SkinHealth Systems Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was $3.30M.
- SkinHealth Systems Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was $386.00K, a 80.18% decline year-over-year.
- SkinHealth Systems Inc. income tax expense (benefit) for fiscal 2025 was $3.58M.
- SkinHealth Systems Inc. income tax expense (benefit) for fiscal 2024 was -$452.00K.
- SkinHealth Systems Inc. income tax expense (benefit) for fiscal 2023 was -$1.77M, a 259.01% decline from fiscal 2022.
- SkinHealth Systems Inc. income tax expense (benefit) for fiscal 2022 was $1.11M.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 3 month as first filed | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month | Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.21M 10-Q · filed 2026-08-06 | $1.02M 10-Q · filed 2026-08-06 | $4.32M derived: sum of 3 quarters · filed 2026-08-06 | $4.71M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | -$184.00K 10-Q · filed 2026-05-07 | $3.11M derived: sum of 2 quarters · filed 2026-05-07 | $3.50M derived: sum of 3 quarters · filed 2026-05-07 | $2.50M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $3.68M derived: sum of 2 quarters · filed 2026-03-12 | $2.69M derived: sum of 3 quarters · filed 2026-08-06 | $3.58M 10-K · filed 2026-03-12 | ||
| 2025-09-30 | $386.00K 10-Q · filed 2025-11-06 | -$607.00K derived: sum of 2 quarters · filed 2026-08-06 | $285.00K 10-Q · filed 2025-11-06 | -$1.10M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | -$993.00K 10-Q · filed 2026-08-06 | -$101.00K 10-Q · filed 2026-08-06 | -$1.49M derived: sum of 3 quarters · filed 2026-08-06 | $459.00K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $892.00K 10-Q · filed 2026-05-07 | -$496.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.45M derived: sum of 3 quarters · filed 2026-05-07 | $1.10M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | -$1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $560.00K derived: sum of 2 quarters · filed 2026-03-12 | $207.00K derived: sum of 3 quarters · filed 2026-03-12 | -$452.00K 10-K · filed 2026-03-12 | ||
| 2024-09-30 | $1.95M 10-Q · filed 2025-11-06 | $1.59M derived: sum of 2 quarters · filed 2025-11-06 | $936.00K 10-Q · filed 2025-11-06 | $1.54M derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2024-06-30 | -$353.00K 10-Q · filed 2025-08-07 | -$1.01M 10-Q · filed 2025-08-07 | -$409.00K derived: sum of 3 quarters · filed 2026-03-12 | $3.07M derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2024-03-31 | -$659.00K 10-Q · filed 2025-05-08 | -$56.00K derived: sum of 2 quarters · filed 2026-03-12 | $3.42M derived: sum of 3 quarters · filed 2026-03-12 | $1.23M derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2023-12-31 | $603.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $4.08M derived: sum of 2 quarters · filed 2026-03-12 | $1.89M derived: sum of 3 quarters · filed 2026-03-12 | -$1.77M 10-K · filed 2026-03-12 | ||
| 2023-09-30 | $3.48M 10-Q · filed 2024-11-12 | $1.29M derived: sum of 2 quarters · filed 2024-11-12 | -$2.38M 10-Q · filed 2024-11-12 | -$3.13M derived: sum of 4 quarters · filed 2025-03-12 | ||
| 2023-06-30 | -$2.19M 10-Q · filed 2024-08-08 | -$5.86M 10-Q · filed 2024-08-08 | -$6.61M derived: sum of 3 quarters · filed 2025-03-12 | -$7.43M derived: sum of 4 quarters · filed 2025-03-12 | ||
| 2023-03-31 | -$3.66M 10-Q · filed 2024-05-09 | -$4.42M derived: sum of 2 quarters · filed 2025-03-12 | -$5.24M derived: sum of 3 quarters · filed 2025-03-12 | -$5.16M derived: sum of 4 quarters · filed 2025-03-12 | ||
| 2022-12-31 | -$755.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | -$1.58M derived: sum of 2 quarters · filed 2025-03-12 | -$1.50M derived: sum of 3 quarters · filed 2025-03-12 | $1.11M 10-K · filed 2025-03-12 | $648.00K 10-K · filed 2023-03-01 | |
| 2022-09-30 | -$821.00K 10-Q · filed 2023-11-14 | -$745.00K derived: sum of 2 quarters · filed 2023-11-14 | $1.87M 10-Q · filed 2023-11-14 | $3.30M derived: sum of 4 quarters · filed 2024-03-12 | ||
| 2022-06-30 | $76.00K 10-Q · filed 2023-08-09 | $2.69M 10-Q · filed 2023-08-09 | $4.12M derived: sum of 3 quarters · filed 2024-03-12 | $2.99M derived: sum of 4 quarters · filed 2024-03-12 | ||
| 2022-03-31 | $2.62M 10-Q · filed 2023-05-10 | $4.04M derived: sum of 2 quarters · filed 2024-03-12 | $2.92M derived: sum of 3 quarters · filed 2024-03-12 | $1.05M derived: sum of 4 quarters · filed 2024-03-12 | ||
| 2021-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $301.00K derived: sum of 2 quarters · filed 2024-03-12 | -$1.57M derived: sum of 3 quarters · filed 2024-03-12 | -$1.88M 10-K · filed 2024-03-12 | -$2.24M 10-K · filed 2022-03-01 | |
| 2021-09-30 | -$1.13M 10-Q · filed 2022-11-09 | -$3.00M derived: sum of 2 quarters · filed 2022-11-09 | -$3.31M 10-Q · filed 2022-11-09 | -$6.35M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | -$1.87M 10-Q · filed 2022-08-09 | -$2.18M 10-Q · filed 2022-08-09 | -$5.22M derived: sum of 3 quarters · filed 2023-03-01 | -$5.82M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | -$306.00K 10-Q · filed 2022-05-10 | $0.00 10-Q · filed 2021-07-01 | -$3.35M derived: sum of 2 quarters · filed 2023-03-01 | -$3.95M derived: sum of 3 quarters · filed 2023-03-01 | -$7.00M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | -$3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$3.64M derived: sum of 2 quarters · filed 2023-03-01 | -$6.69M derived: sum of 3 quarters · filed 2023-03-01 | -$9.31M 10-K · filed 2023-03-01 | ||
| 2020-09-30 | -$593.00K 10-Q · filed 2021-11-12 | -$3.65M derived: sum of 2 quarters · filed 2021-11-12 | -$6.26M 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | -$3.05M 10-Q · filed 2021-08-13 | -$5.67M 10-Q · filed 2021-08-13 | ||||
| 2019-12-31 | -$1.30M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |